Under pressure from Congress to determine whether to add
four diseases to the list of Agent Orange-related conditions, Department of
Veterans Affairs officials have disputed a scientific panel’s findings and said
they will wait for additional research to conclude before making what could be
a $15.2 billion decision.
In a report sent to the House and Senate Veterans Affairs
committees on Monday, VA Secretary Robert Wilkie said VA experts “noted
significant concerns and limitations” with several National Academies of
Sciences, Engineering and Medicine, or NASEM, reports concluding that there is
suggestive or sufficient evidence linking development
of bladder cancer, hypothyroidism, Parkinson’s-like tremors and hypertension
to exposure to herbicides for defoliation in the Vietnam War.
According to Wilkie, NASEM did not identify any “definitive
causal links” between Agent Orange and the diseases, and at least two —
hypertension and bladder cancer — have other risk factors besides herbicide
exposure, such as age, diet and tobacco use, that can contribute to their
development.
White House responsible for delayed decision on new Agent
Orange diseases, documents show
Internal documents reveal the disagreements within the Trump
administration over adding new Agent Orange-connected diseases.
Also, Wilkie said, members of the NASEM panel, in drawing
their conclusions, relied heavily on studies of Army Chemical Corps members
“with known high occupational exposure” that don’t necessarily reflect the
experience of most U.S. troops in Vietnam.
Given the concerns and the cost, which according to VA could
run between $11.2 billion and $15.2 billion, depending on interpretations of a
court ruling, VA is waiting for the results of its own studies, expected later
this year, to announce any decision, the report says.